Pathergy Test in Behçet's Disease
The pathergy test is performed by intradermal needle prick (preferably using 2 pricks with a blunt 20-gauge needle) and read at 48 hours, with a positive result defined as development of a papule/pustule ≥2mm or erythema ≥15mm at the prick site.
Test Performance Technique
The optimal technique for pathergy testing has been refined through multiple studies:
Needle type matters significantly: Use blunt needles rather than sharp ones, as blunt needles demonstrate markedly higher sensitivity while maintaining 100% specificity 1. The shift to disposable sharp needles in the post-AIDS era has contributed to decreased test positivity 2.
Needle gauge: A 20-gauge (0.9mm diameter) needle yields maximum positivity (65%), while thinner 26-gauge needles show considerably less reactivity 2.
Number of pricks: Apply 2 needle pricks per test site. While increasing from 1 to 6 pricks progressively increases positivity (13% to 33%), the greatest incremental gain occurs when moving from 1 to 2 pricks (13% to 19%), making 2 pricks the optimal balance between sensitivity and practicality 3.
Interpretation Criteria
Traditional Interpretation
A positive test traditionally requires development of a papule or pustule ≥2mm at the needle prick site 4. However, pustule formation is rare, occurring in only about 1% of positive cases 4.
Modified Interpretation for Western Populations
In Western European populations where classic pathergy positivity is lower, erythema ≥15mm at the self-saliva prick test site demonstrates 42.3% sensitivity and 91% specificity for Behçet's disease 5. This modified criterion may be more clinically useful in these geographic regions.
Important Caveats
Geographic variation: Pathergy positivity varies dramatically by geography—higher along the Silk Road regions, lower in Western populations 5.
Specificity is excellent: When positive, the test is highly specific for Behçet's disease, with essentially no false positives in healthy controls or other disease controls when using proper technique 1, 4.
Sensitivity is limited: Only 35-42% of Behçet's patients demonstrate positive pathergy 5, 4, making it useful when positive but not excluding the diagnosis when negative.
Disease activity correlation: Pathergy positivity is more commonly observed during active disease phases, though it can occasionally persist during remission 4. The test shows significant association with active folliculitis (40.7% positive vs 19.2% without folliculitis) 6.
Venous puncture sites: Patients who develop pustule formation at venous puncture sites (PFVPS) without classic positive pathergy may warrant venous pathergy testing, which can be positive in 87.5% of such cases 4.
Clinical Application
The pathergy test serves as an adjunctive diagnostic tool with good specificity but limited sensitivity. A positive result strongly supports the diagnosis of Behçet's disease, but a negative result does not exclude it. The test is most valuable in patients from endemic regions and should be interpreted alongside clinical criteria rather than as a standalone diagnostic marker.